GSK Pakistan: Notice of Interim Cash Dividend and Bonus Issue — Shareholders Must Update Bank/IBAN & CNIC Details

Issuer: GlaxoSmithKline (GSK) Pakistan. The Board has approved an interim distribution comprising a cash dividend and a bonus/stock issue. Shareholders are instructed on the payment methods and documentation required to receive their entitlements.

Key actions for shareholders:

• Holdings in CDC accounts: Ensure your bank mandate (IBAN), valid CNIC/NICOP and other shareholder information are recorded with the CDC Share Registrar (Investor Account Services / CDC Share Registrar). Payment will be made via the e‑Dividend mechanism where bank details are available.
• Physical shareholders or those without updated bank details should submit the required Bank Mandate Form, copy of CNIC and any other requested documents to the CDC Share Registrar / Investor Account Services as instructed by the company to receive the cash dividend or bonus entitlement.
• Shareholders are directed to CDC e‑services/registrar resources (CDC Share Registrar / Investor Account Services website) to download forms and for submission guidance.
• Payments will be processed in accordance with applicable SECP and tax regulations; shareholders should ensure their records (IBAN, CNIC) are up to date to avoid delays in electronic crediting of funds.

Publication and contact: The notice was published in Karachi. For further details and to obtain the required forms, shareholders should contact the CDC Share Registrar / Investor Account Services or consult CDC’s e‑services pages.